Table 3.
Index | Time (d) | Sham-operation group | Model control group | Treatment group |
Pathological severity score | 7 | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0)c |
14 | 0.0 (1.0)c | 0.0 (2.0) | 0.0 (0.0)c | |
21 | 0.0 (0.0) | 1.0 (2.0) | 0.0 (0.0) | |
28 | 0.0 (0.0) | 0.0 (1.0) | 0.0 (0.0) | |
Product staining intensity and positive rate of Bax | 7 | 0.0 (0.0)c | 1.0 (2.0) | 0.5 (1.0)a |
14 | 0.0 (1.0) | 1.0 (2.0) | 0.0 (0.0)c | |
21 | 0.0 (0.0)c | 1.0 (2.0) | 0.0 (2.0) | |
28 | 0.0 (0.0)c | 2.0 (1.5) | 0.0 (1.0)c | |
Apoptosis index | 7 | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) |
14 | 0.0 (0.0) | 0.0 (0.01) | 0.0 (0.0)c | |
21 | 0.0 (0.0)c | 0.0 (0.01) | 0.0 (0.0) | |
28 | 0.0 (0.0)c | 0.01 (0.02) | 0.0 (0.0) | |
Product staining intensity and positive rate of NF-κB | 7 | 0.0 (0.0) | 0.0 (1.0) | 0.0 (0.0) |
14 | 0.0 (1.0) | 0.0 (2.0) | 0.0 (0.0) | |
21 | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | |
28 | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) |
P < 0.05 vs sham-operation group;
P < 0.05 vs model control group.